These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The Effect of In-Situ-Generated Moisture on Disproportionation of Pharmaceutical Salt. Weldeab AO; McElderry JD; Lin Y Mol Pharm; 2023 Jan; 20(1):561-571. PubMed ID: 36524757 [TBL] [Abstract][Full Text] [Related]
25. Impact of Solid-State Form on the Disproportionation of Miconazole Mesylate. Patel MA; Luthra S; Shamblin SL; Arora K; Krzyzaniak JF; Taylor LS Mol Pharm; 2018 Jan; 15(1):40-52. PubMed ID: 29202237 [TBL] [Abstract][Full Text] [Related]
26. Effect of processing and formulation variables on the stability of a salt of a weakly basic drug candidate. Badawy S; Vickery R; Shah K; Hussain M Pharm Dev Technol; 2004 Aug; 9(3):239-45. PubMed ID: 15458230 [TBL] [Abstract][Full Text] [Related]
27. Univariate and Multivariate Models for Determination of Prasugrel Base in the Formulation of Prasugrel Hydrochloride Using XRPD Method. Dharani S; Barakh Ali SF; Afrooz H; Khan MA; Rahman Z J Pharm Sci; 2019 Nov; 108(11):3575-3581. PubMed ID: 31276685 [TBL] [Abstract][Full Text] [Related]
28. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration. Yang B; Wei C; Yang Y; Wang Q; Li S Drug Dev Ind Pharm; 2018 Sep; 44(9):1417-1425. PubMed ID: 29557692 [TBL] [Abstract][Full Text] [Related]
30. Implementing quality by design in pharmaceutical salt selection: a modeling approach to understanding disproportionation. Merritt JM; Viswanath SK; Stephenson GA Pharm Res; 2013 Jan; 30(1):203-17. PubMed ID: 22918819 [TBL] [Abstract][Full Text] [Related]
31. Effect of Microenvironmental pH Modulation on the Dissolution Rate and Oral Absorption of the Salt of a Weak Acid - Case Study of GDC-0810. Hou HH; Jia W; Liu L; Cheeti S; Li J; Nauka E; Nagapudi K Pharm Res; 2018 Jan; 35(2):37. PubMed ID: 29380076 [TBL] [Abstract][Full Text] [Related]
32. Understanding the Roles of Excipients in Moisture Management in Solid Dosage Forms. Veronica N; Heng PWS; Liew CV Mol Pharm; 2024 May; 21(5):2484-2500. PubMed ID: 38647432 [TBL] [Abstract][Full Text] [Related]
33. Formulation development of sugar free antacid chewable tablets for diabetes induced acidity in patients. Khan M; Rehman H; Ayaz S; Qamar F; Owais A; Sana A; Naveed S Pak J Pharm Sci; 2019 Nov; 32(6(Supplementary)):2811-2816. PubMed ID: 32024618 [TBL] [Abstract][Full Text] [Related]
34. Analytical approaches to investigate salt disproportionation in tablet matrices by Raman spectroscopy and Raman mapping. Nie H; Liu Z; Marks BC; Taylor LS; Byrn SR; Marsac PJ J Pharm Biomed Anal; 2016 Jan; 118():328-337. PubMed ID: 26590700 [TBL] [Abstract][Full Text] [Related]
36. Salt Solubility and Disproportionation - Uses and Limitations of Equations for pH Avdeef A; Sugano K J Pharm Sci; 2022 Jan; 111(1):225-246. PubMed ID: 34863819 [TBL] [Abstract][Full Text] [Related]
37. An investigation into the impact of magnesium stearate on powder feeding during roller compaction. Dawes J; Gamble JF; Greenwood R; Robbins P; Tobyn M Drug Dev Ind Pharm; 2012 Jan; 38(1):111-22. PubMed ID: 21810064 [TBL] [Abstract][Full Text] [Related]
38. Mechanism and Impact of Excipient Incompatibility: Cross-Linking of Xanthan Gum in Pediatric Powder-for-Suspension Formulations. Li Y; Zhang D; Ash J; Jia X; Leone A; Templeton A J Pharm Sci; 2019 Nov; 108(11):3609-3615. PubMed ID: 31348935 [TBL] [Abstract][Full Text] [Related]
39. Stability of pharmaceutical salts in solid oral dosage forms. Nie H; Byrn SR; Zhou QT Drug Dev Ind Pharm; 2017 Aug; 43(8):1215-1228. PubMed ID: 28276282 [TBL] [Abstract][Full Text] [Related]
40. Ionization states in the microenvironment of solid dosage forms: effect of formulation variables and processing. Govindarajan R; Zinchuk A; Hancock B; Shalaev E; Suryanarayanan R Pharm Res; 2006 Oct; 23(10):2454-68. PubMed ID: 16933092 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]